|
|||||
|
|
| Back | Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| HUM | William K. Fleming | Officer | Dec 06 '24 | Proposed Sale | 283.06 | 8,661 | 2,451,583 | Dec 06 04:35 PM | |
| HUM | Fleming William Kevin | Seg Pres, Pharmacy Sol & CCAO | Nov 03 '22 | Sale | 565.61 | 11,157 | 6,310,551 | 2,542 | Nov 07 12:52 PM |
| HUM | Fleming William Kevin | Seg Pres, Pharmacy Sol & CCAO | Apr 28 '22 | Sale | 449.68 | 3,210 | 1,443,471 | 884 | May 02 01:34 PM |
| HUM | Fleming William Kevin | Seg Pres, Clin & Phm Solutions | May 04 '21 | Sale | 459.29 | 8,899 | 4,087,205 | 4,862 | May 06 11:25 AM |
| HUM | Fleming William Kevin | Seg Pres, Clin & Phm Solutions | Feb 23 '21 | Sale | 378.26 | 4,378 | 1,656,044 | 5,969 | Feb 23 06:34 PM |
| HUM | Fleming William Kevin | Seg Pres, Clin & Phm Solutions | Dec 16 '20 | Sale | 395.23 | 860 | 339,898 | 5,960 | Dec 17 01:45 PM |
| HUM | Fleming William Kevin | Seg Pres, Clin & Phm Solutions | Nov 04 '20 | Sale | 451.71 | 11,373 | 5,137,273 | 7,832 | Nov 06 01:10 PM |
| HUM | Fleming William Kevin | Seg Pres, Clin & Phm Solutions | Dec 16 '19 | Sale | 354.43 | 13,131 | 4,653,970 | 6,663 | Dec 17 02:25 PM |
| HUM | Fleming William Kevin | Seg President, Healthcare Svcs | Dec 18 '18 | Sale | 295.03 | 2,043 | 602,738 | 7,323 | Dec 18 04:09 PM |
| HUM | Fleming William Kevin | Seg President, Healthcare Svcs | Jun 04 '18 | Sale | 293.08 | 15,637 | 4,582,884 | 8,023 | Jun 05 02:56 PM |
| HUM | Fleming William Kevin | Seg President, Healthcare Svcs | Feb 28 '18 | Sale | 275.35 | 1,073 | 295,450 | 8,143 | Mar 01 02:11 PM |
| HUM | Fleming William Kevin | President, Hlthcare Svc Sgmt | Aug 23 '17 | Sale | 250.98 | 3,071 | 770,760 | 7,681 | Aug 25 01:32 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite